Discover the Power of Predict IQ: Powered by GARS

The GARS system stands as the most researched and comprehensive behavioral health genetic platform available today. We hold the world’s leading genetic intellectual property in this space, encompassing a wide range of conditions including addiction, OCD, impulsive behavior, ADD/ADHD, PTSD, and beyond—all rooted in Reward Deficiency Syndrome (RDS).

But it doesn’t stop at genetics. We pair this groundbreaking insight with Synapta+, our personalized neuro-nutrient formula that’s undergone over 30 clinical trials, including NIH funded studies, to support dopamine balance and overall brain health.

Dive into our Clinical Dossier below for some of our most impactful research, starting with an in-depth exploration of Predict IQ’s core technology and its transformative approach to nutrigenomics.